NIH Awards $9.8M Grant to Research Consortium for HIV Vaccine Development
University of Washington is part of a consortium led by Seattle Biomed to develop a vaccine that would elicit broadly neutralizing antibodies against HIV-1. The $9.8m grant from NIH was announced March 10. Other members of the consortium include Seattle Children's Hospital and the Fred Hutchinson Cancer Research Center.
Seattle Biomed Scientific Director Leonidas Stamatatos, PhD, an Affiliate Professor of Global Health will serve as program principal investigator, and will lead the initial phase of the project, which includes the optimization of immunogens.